US EditionPublished • loading... • Updated
Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Updates
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Updates
Several analysts have recently updated their ratings and price targets for Mirum Pharmaceuticals (NASDAQ: MIRM): 12/19/2025 – Mirum Pharmaceuticals had its “outperform” rating reaffirmed by analysts at Citigroup Inc.. 12/19/2025 – Mirum Pharmaceuticals had its price target raised by analysts at Citizens Jmp from $95.00 to $140.00. They now have a “market outperform” rating on […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
